Privia Health Group Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Privia Health Group Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- PRVA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001759655
Board of directors
-
Adam Boehler · DirectorSince 2023
-
David P. King · DirectorSince 2023
-
David S. Wichmann · DirectorSince 2023
-
Jaewon Ryu · DirectorSince 2023
-
Jeffrey Daniel Bernstein · DirectorSince 2023
-
Lance Berberian · DirectorSince 2025
-
Matthew Shawn Morris · Director · Chief Executive OfficerSince 2023
-
Nancy G. Cocozza · DirectorSince 2023
-
Pamela O. Kimmet · DirectorSince 2023
-
Parth Mehrotra · Director · Chief Executive OfficerSince 2023
-
Patricia Anne Maryland · DirectorSince 2023
-
Thomas A. McCarthy · DirectorSince 2023
-
William M. Sullivan · DirectorSince 2023
Chief executives
Matthew Shawn Morris
· Chief Executive Officer
Dates unknown
Parth Mehrotra
· Chief Executive Officer
Dates unknown
Board connections
4 of this board's directors also sit on 5 other boards.
- via David S. Wichmann
- via Patricia Anne Maryland
- via Thomas A. McCarthy
- via Patricia Anne Maryland
- via Jaewon Ryu
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $939,203
- 2 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 12, 2025 | Matthew Shawn Morris Director | Option exercise | +13,647 | $2.00 | $27,294 |
| Dec 12, 2025 | Mountcastle David Officer (EVP & Chief Financial Officer) | Option exercise | +23,887 | $2.00 | $47,774 |
| Dec 12, 2025 | Matthew Shawn Morris Director | Open-market sale | −13,647 | $25.01 | $341,311 |
| Dec 12, 2025 | Mountcastle David Officer (EVP & Chief Financial Officer) | Open-market sale | −23,887 | $25.03 | $597,892 |
| Jul 15, 2025 | Lance Berberian Director | Grant or award | +7,668 | — | — |
| May 21, 2025 | Thomas A. McCarthy Director | Grant or award | +8,396 | — | — |
| May 21, 2025 | David P. King Director | Grant or award | +8,396 | — | — |
| May 21, 2025 | David S. Wichmann Director | Grant or award | +8,396 | — | — |
| May 21, 2025 | Nancy G. Cocozza Director | Grant or award | +8,396 | — | — |
| May 21, 2025 | Pamela O. Kimmet Director | Grant or award | +8,396 | — | — |
| May 21, 2025 | Patricia Anne Maryland Director | Grant or award | +8,396 | — | — |
| May 21, 2025 | Jaewon Ryu Director | Grant or award | +8,396 | — | — |
| May 21, 2025 | Matthew Shawn Morris Director | Grant or award | +8,396 | — | — |
| May 13, 2025 | Parth Mehrotra Director, Officer (Chief Executive Officer) | Open-market sale | −15,909 | $24.52 | $390,089 |
| May 12, 2025 | Parth Mehrotra Director, Officer (Chief Executive Officer) | Open-market sale | −13,773 | $24.99 | $344,187 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.